Categories: News

MESI joins forces with WEDA medical management software provider for early disease detection in France

LJUBLJANA, Slovenia, April 5, 2022 /PRNewswire/ — WEDA is a leading online management software provider in French healthcare. To take early disease discovery to a new level, it joined forces with the French subsidiary of the Slovenian company MESI, Ltd. This is the developer of the MESI mTABLET – a digital solution combining diverse diagnostic measurements, patient records and medical apps. The two systems have been successfully integrated, so the MESI mTABLET measurements can now be ordered from the WEDA software and instantly stored into WEDA patient files.

Some of the biggest healthcare challenges today are the use of separate diagnostic equipment and incompatible medical software solutions. WEDA, a leader in medical management software in France with over 15,000 users, and MESI, Ltd., an innovator in digital diagnostics, interconnected their systems to change that in French healthcare.

MESI mTABLET offers diverse diagnostics like ECG, spirometry, oximetry, blood pressure, ABI and TBI on one device. For example, its MESI mTABLET ABI helps detect Peripheral Arterial Disease (PAD). This cardiovascular condition has a high mortality rate, but 70% of patients are without symptoms. MESI’s innovation shortens the measurement of the Arm-Brachial Index (ABI, an indicator of PAD) to 1 minute. This could make an important difference because PAD is estimated to affect over 2 million in France.

To make a diagnostic measurement, the health professional clicks on the appropriate icon on their WEDA software. An inquiry is instantly sent to the MESI mTABLET, the measurement is performed and the measurement report is automatically available in the WEDA patient record.

“Easy integration with digital solutions like WEDA, used in national health systems, is one of the main aims of MESI products. This is what healthcare digitalisation is all about: early disease discovery and reduced administrative workload,” says Jakob Šušterič, CEO of MESI, Ltd.

About the company:

MESI, Ltd. is an innovative European company that develops and produces medical devices for diagnostic purposes. It focuses on digitalising medical assessment to simplify diagnostics and help discover diseases early. One of their solutions is the MESI mTABLET – a system combining 1-minute smart wireless ABI, a flexible pulse oximeter, fully digital ECG, wireless TBI, a blood pressure monitor for immediate readings, and a spirometer with real-time animated flow-volume curve.

CONTACT:  Manca Uršič Rosas, +386 1 620 34 87, manca@mesimedical.com

Photo – https://mma.prnewswire.com/media/1778739/MESI_WEDA.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/mesi-joins-forces-with-weda-medical-management-software-provider-for-early-disease-detection-in-france-301516040.html

SOURCE MESI, Ltd.

Staff

Recent Posts

Geek+ implements first Tote-to-Person project in Italy for pharmaceutical chain

DUSSELDORF, Germany, June 27, 2024 /PRNewswire/ -- Geekplus, the global leader in mobile robot and…

1 hour ago

UNGUESS strengthens its international footprint by joining forces with Ferpection

Ferpection, a French company active in User Research since 2014, will join UNGUESS's orbit starting…

1 hour ago

PHARMANUTRA S.P.A.: THE DISTRIBUTION OF IRON-BASED DIETARY SUPPLEMENTS KICKS OFF IN MEXICO

Partner SMS Pharma will market the three products in the SiderAL® line under the trade name…

1 hour ago

LabTrace Completes the First Study Using its Blockchain-Based Data Authentication System, Designed to Ensure Data Integrity in Clinical Trials

Parkinson's disease research, sponsored by King's College London, verifies clinical observation data using the Algorand…

1 hour ago

Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION…

4 hours ago